HQY vs GMED

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

HQY

41.4
AI Score
VS
HQY Wins

GMED

31.9
AI Score

Investment Advisor Scores

HQY

41score
Recommendation
HOLD

GMED

32score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric HQY GMED Winner
Forward P/E 20.4499 19.3424 GMED
PEG Ratio 1.3638 1.7253 HQY
Revenue Growth 7.2% 5.9% HQY
Earnings Growth 34.4% -26.2% HQY
Tradestie Score 41.4/100 31.9/100 HQY
Profit Margin 17.2% 17.0% HQY
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL HQY

Relative Price Performance (Last 90 Days)

HQY 1M: +11.7% · 3M: +22.0% GMED 1M: +15.2% · 3M: +2.7%

Current Technical Phase

HQY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.6% over 20 days), RSI 62

RSI (14): 61.6 · Price: $105.41

GMED

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.4% over 20 days), RSI 61

RSI (14): 60.7 · Price: $86.91

Fundamentals Snapshot

Metric HQY GMED
Market Cap
Forward P/E 23.2 16.2
Trailing P/E 38.9 22.5
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.7% 0.7%
Operating Margin 0.3% 0.2%
EPS 2.68 3.80
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HQY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.